Rheumatic fever and rheumatic heart disease: Primary prevention is the cost effective option
Purchase on Springer.com
$39.95 / €34.95 / £29.95*
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.
To measure the economic output/input ratios for the various options of prevention of rheumatic fever/rheumatic heart disease (RF/RHD) and check the viability of primary prevention vis-à-vis secondary and tertiary preventions.
Cost accounting of the various prevention options was calculated for each variable as available in literature. Actual data as obtainable for the financial year ending March 2006 were computed for the Pondicherry population. Both direct and indirect costs (including community/social costs) were worked out using mostly primary data, and wherever necessary, secondary data. Certain scientific assumptions were used where exact data was not available.
Primary prevention is the definite viable economic option (1:1.56) compared to secondary (1: 1.07) and tertiary (1: 0.12) preventions. In fact, the current stress on only secondary and tertiary preventions is found to be economically unviable.
It is postulated that primary prevention as a practical policy in tackling RF and RHD can be recommended.
- WHO. Technical Report Series. 1988; 764: 1–58.
- McLaren MJ, Markowitz M, Gerber MA. Rheumatic Heart Disease in developing countries: The consequence of inadequate prevention. Ann Intern Med 1994; 120(3): 3–5.
- Sobhan Nandi, Rajesh Kumar, Pallab Ray, Harpreet Vohra, NK Ganguly. Group A Streptococcal sore throat in a periurban population of Northern India: a one-year Prospective study. Bull World Health Organ 2001; 79(6): 528–533.
- WHO. Technical Report Series, No. 923. 2001: 23, 69, 70, 83, 85, 91, 111
- Census of India 2001 — Series 1: Registrar General and Census Commissioner, India
- Padmavathi S. Present status of rheumatic fever and rheumatic heart disease in India. Indian Heart J 2001; 53(1): 35–37.
- Personal communications based on interaction with concerned departments in JIPMER
- World Development Indices from World Bank, April 2004 (www.finfacts.com/biz10/globalworldincomepercapita.htm)
- Ravisha MS, Tullu MS, Kamat JR. Rheumatic fever and rheumatic heart disease: clinical profile of 550 cases in India. Arch Med Res 2003; 34(5): 382–387. CrossRef
- Park K. Textbook of Preventive and Social Medicine, 18th ed. Jabalpur; M/s Banarsida Bhanot, 2005; 299–300.
- Rheumatic fever and rheumatic heart disease: Primary prevention is the cost effective option
The Indian Journal of Pediatrics
Volume 74, Issue 6 , pp 567-570
- Cover Date
- Print ISSN
- Online ISSN
- Additional Links
- Health economics
- Rheumatic fever
- Rheumatic heart disease
- Primary prevention
- Direct and indirect costs
- Social and community costs
- Industry Sectors
- Author Affiliations
- 6. Department of Preventive and Social Medicine, JIPMER, Pondicherry, 605 006, India
- 1. Surgery, Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Pondicherry, India
- 2. Biometrics, Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Pondicherry, India
- 3. Pediatrics, Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Pondicherry, India
- 4. Cardio-Thoracic & Vascular Surgery, Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Pondicherry, India
- 5. Cardiology, Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Pondicherry, India